What one share of Creative Medical Technology Holdings holds
We are a commercial stage biotechnology company dedicated to the advancement regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. Our platforms, therapies and products include the following:
Creative Medical Technology Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$1.96 |
| Cash and investments | $1.34 |
| Book value | $1.33 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $0.01 | −$3.76 | — | — | — | $7.53 |
| 2024 | $0.01 | −$3.71 | — | — | — | $3.63 |
| 2025 | $0.00 | −$2.52 | — | — | — | $2.03 |
Common questions about Creative Medical Technology Holdings
How much does one share of Creative Medical Technology Holdings earn?
Over the last 12 months, Creative Medical Technology Holdings lost $1.96 for each share on $0.00 of sales.
Does Creative Medical Technology Holdings pay a dividend?
Creative Medical Technology Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Creative Medical Technology Holdings’s book value per share?
Creative Medical Technology Holdings’s book value is $1.33 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Creative Medical Technology Holdings have?
Each share of Creative Medical Technology Holdings has $1.34 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.